AMAG Pharmaceuticals Reports Fourth Quarter and Full Year 2019 Financial Results and Provides Corporate Update
March 04, 2020 07:00 ET
|
AMAG Pharmaceuticals, Inc.
WALTHAM, Mass., March 04, 2020 (GLOBE NEWSWIRE) -- AMAG Pharmaceuticals, Inc. (NASDAQ: AMAG) today reported unaudited consolidated financial results for the fourth quarter and full year ended...
AMAG Pharmaceuticals Announces Changes to Medical Development Organization
March 04, 2020 06:58 ET
|
AMAG Pharmaceuticals, Inc.
WALTHAM, Mass., March 04, 2020 (GLOBE NEWSWIRE) -- AMAG Pharmaceuticals, Inc. (NASDAQ: AMAG) today announced changes to its medical development organization. Effective March 31, 2020, Julie Krop,...
AMAG Pharmaceuticals to Host Fourth Quarter and Full Year 2019 Financial Results Conference Call and Webcast on Wednesday, March 4, 2020 at 8:00 a.m. ET
February 28, 2020 08:00 ET
|
AMAG Pharmaceuticals, Inc.
WALTHAM, Mass., Feb. 28, 2020 (GLOBE NEWSWIRE) -- AMAG Pharmaceuticals, Inc. (NASDAQ: AMAG) today announced that its fourth quarter and full year 2019 financial results will be released on...
AMAG Pharmaceuticals to Participate in Upcoming Investor Conferences
February 14, 2020 08:00 ET
|
AMAG Pharmaceuticals, Inc.
WALTHAM, Mass., Feb. 14, 2020 (GLOBE NEWSWIRE) -- AMAG Pharmaceuticals, Inc. (NASDAQ: AMAG) today announced that management will participate in the following investor conferences: SVB Leerink 9th...
AMAG Pharmaceuticals Announces Leadership Transition, Results of Strategic Review to Unlock Shareholder Value and Financial Update
January 09, 2020 07:00 ET
|
AMAG Pharmaceuticals, Inc.
Initiating CEO transition plan Divesting Intrarosa® and Vyleesi® 2020 financial guidance reflects reduction in annual operating expenses of more than $100M and a return to positive adjusted EBITDA ...
AMAG Pharmaceuticals to Present at the 38th Annual J.P. Morgan Healthcare Conference
January 03, 2020 08:00 ET
|
AMAG Pharmaceuticals, Inc.
WALTHAM, Mass., Jan. 03, 2020 (GLOBE NEWSWIRE) -- AMAG Pharmaceuticals, Inc. (NASDAQ: AMAG) today announced that management will present at the 38th Annual J.P. Morgan Healthcare Conference on...
AMAG Pharmaceuticals Awards Four Grants to Support Preterm Birth and Preeclampsia Research
December 18, 2019 08:00 ET
|
AMAG Pharmaceuticals, Inc.
WALTHAM, Mass., Dec. 18, 2019 (GLOBE NEWSWIRE) -- As part of the company’s ongoing support of research to reduce preterm birth and preeclampsia and associated complications, AMAG Pharmaceuticals,...
AMAG Pharmaceuticals to Present at Upcoming Investor Conferences
November 13, 2019 08:00 ET
|
AMAG Pharmaceuticals, Inc.
WALTHAM, Mass., Nov. 13, 2019 (GLOBE NEWSWIRE) -- AMAG Pharmaceuticals, Inc. (NASDAQ:AMAG) today announced that company management will participate in the following investor conferences: Jefferies...
AMAG Pharmaceuticals Announces Third Quarter 2019 Financial Results and Provides Corporate Update
November 01, 2019 07:00 ET
|
AMAG Pharmaceuticals, Inc.
Commercial products achieve strong revenue and market share performance Vyleesi™ (bremelanotide injection) launched nationally in September Committed to work with the FDA to keep Makena available...
AMAG Reports on FDA Advisory Committee Meeting for Makena® (Hydroxyprogesterone Caproate Injection)
October 29, 2019 21:39 ET
|
AMAG Pharmaceuticals, Inc.
WALTHAM, Mass., Oct. 29, 2019 (GLOBE NEWSWIRE) -- AMAG Pharmaceuticals, Inc. (NASDAQ:AMAG) today announced the U.S. Food and Drug Administration’s (FDA) Bone, Reproductive and Urologic Drugs...